Recursion Pharmaceuticals Inc vs Super Micro Computer Inc — how do they compare? Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B), while Super Micro Computer Inc trades at $29.67 (market cap $15.41B). The key difference: Super Micro Computer Inc is far larger — about 10.1× Recursion Pharmaceuticals Inc's market cap, and Super Micro Computer Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| RXRX | SMCI | |
|---|---|---|
Market Cap | $1.53B | $15.41B |
Sector | Health | Technology |
52-Week High | $6.79 | $60.71 |
52-Week Low | $2.84 | $20.53 |
Enterprise Value | $946.50M | $22.93B |
Trailing returns across standard periods
Latest headlines on both assets
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →